<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Saragliadis A</submitter><funding>Novo Nordisk Fonden</funding><pagination>100025</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7388967</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5</volume><pubmed_abstract>We set out to develop scalable assays to measure bacterial adhesion to mammalian extracellular matrix proteins, with the aim to perform high-throughput screening for inhibitors. Our model system is the trimeric autotransporter adhesin YadA from &lt;i>Yersinia enterocolitica&lt;/i> that binds to collagen. Using bacterial cells expressing GFP under an inducible promotor, and co-expressing the adhesin of choice, we were able to establish a 384-well plate-based assay that allowed us to screen 28,000 compounds in 8 days (3520 compounds per day). We have collected all parameters that were essential in assay development, and describe how they can be tuned for improved performance. Out of 28,000 compounds, 5 compounds showed significant inhibitory activity, measured as loss of fluorescence compared to c</pubmed_abstract><journal>Cell surface (Amsterdam, Netherlands)</journal><pubmed_title>Assay development for the discovery of small-molecule inhibitors of YadA adhesion to collagen.</pubmed_title><pmcid>PMC7388967</pmcid><funding_grant_id>NNF18OC0032818</funding_grant_id><pubmed_authors>Saragliadis A</pubmed_authors><pubmed_authors>Linke D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assay development for the discovery of small-molecule inhibitors of YadA adhesion to collagen.</name><description>We set out to develop scalable assays to measure bacterial adhesion to mammalian extracellular matrix proteins, with the aim to perform high-throughput screening for inhibitors. Our model system is the trimeric autotransporter adhesin YadA from &lt;i>Yersinia enterocolitica&lt;/i> that binds to collagen. Using bacterial cells expressing GFP under an inducible promotor, and co-expressing the adhesin of choice, we were able to establish a 384-well plate-based assay that allowed us to screen 28,000 compounds in 8 days (3520 compounds per day). We have collected all parameters that were essential in assay development, and describe how they can be tuned for improved performance. Out of 28,000 compounds, 5 compounds showed significant inhibitory activity, measured as loss of fluorescence compared to c</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-05T15:21:00.584Z</modification><creation>2025-04-05T15:21:00.584Z</creation></dates><accession>S-EPMC7388967</accession><cross_references><pubmed>32743141</pubmed><doi>10.1016/j.tcsw.2019.100025</doi></cross_references></HashMap>